Search research articles
Contact Us
Filters
Showing results (101-110 of 115) with videos related to
Page
of 12
Sort By:
Molecular Cancer Therapeutics
|
October 9, 2012
Regression of human prostate cancer xenografts in mice by AMG 212/BAY2010112, a novel PSMA/CD3-Bispecific BiTE antibody cross-reactive with non-human primate antigens
Matthias Friedrich, Tobias Raum, Ralf Lutterbuese, et al.
The Science of the Total Environment
|
August 26, 2024
Deep desert aquifers as an archive for Mid- to Late Pleistocene hydroclimate: An example from the southeastern Mediterranean
Roi Ram, Eilon M Adar, Yoseph Yechieli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2010
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study
Martin Kocher, Riccardo Soffietti, Ufuk Abacioglu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma
Liz Y Han, Mavis S Fletcher, Diana L Urbauer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 12, 2015
Short-interval observational data to inform clinical trial design in Huntington's disease
Nicola Z Hobbs, Ruth E Farmer, Elin M Rees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2012
A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results
Riccardo Soffietti, Martin Kocher, Ufuk M Abacioglu, et al.
Blood
|
September 2, 2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
Carsten Kobe, Markus Dietlein, Jeremy Franklin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2011
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group
Peter Borchmann, Heinz Haverkamp, Volker Diehl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 2, 2008
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'
Sandra Collette, Laurence Collette, Tom Budiharto, et al.
Transplantation and Cellular Therapy
|
May 7, 2025
Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
Alexander Denk, Matthias Alexander Fante, Silke Heidenreich, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 115) with videos related to
Sort By:
Page
of 12
Molecular Cancer Therapeutics
|
October 9, 2012
Regression of human prostate cancer xenografts in mice by AMG 212/BAY2010112, a novel PSMA/CD3-Bispecific BiTE antibody cross-reactive with non-human primate antigens
Matthias Friedrich, Tobias Raum, Ralf Lutterbuese, et al.
The Science of the Total Environment
|
August 26, 2024
Deep desert aquifers as an archive for Mid- to Late Pleistocene hydroclimate: An example from the southeastern Mediterranean
Roi Ram, Eilon M Adar, Yoseph Yechieli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 3, 2010
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study
Martin Kocher, Riccardo Soffietti, Ufuk Abacioglu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma
Liz Y Han, Mavis S Fletcher, Diana L Urbauer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 12, 2015
Short-interval observational data to inform clinical trial design in Huntington's disease
Nicola Z Hobbs, Ruth E Farmer, Elin M Rees, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2012
A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results
Riccardo Soffietti, Martin Kocher, Ufuk M Abacioglu, et al.
Blood
|
September 2, 2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
Carsten Kobe, Markus Dietlein, Jeremy Franklin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2011
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group
Peter Borchmann, Heinz Haverkamp, Volker Diehl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 2, 2008
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'
Sandra Collette, Laurence Collette, Tom Budiharto, et al.
Transplantation and Cellular Therapy
|
May 7, 2025
Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
Alexander Denk, Matthias Alexander Fante, Silke Heidenreich, et al.
Page
of 12